Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 5146 AL 5160

Lecanemab for Alzheimer's disease: tempering hype and hope

The Lancet.

Lancet. 2022 Dec 3;400(10367):1899. doi: 10.1016/S0140-6736(22)02480-1.

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease

Du H, Meng X, Yao Y, Xu J.

Front Endocrinol (Lausanne). 2022 Nov 17;13:1033479. doi: 10.3389/fendo.2022.1033479. eCollection 2022.

Association between Porphyromonas Gingivalis and systemic diseases: Focus on T cells-mediated adaptive immunity

Li C, Yu R, Ding Y.

Front Cell Infect Microbiol. 2022 Nov 17;12:1026457. doi: 10.3389/fcimb.2022.1026457. eCollection 2022.

Self-Assembly of Amyloid-Beta (Aβ) Peptides from Solution to Near In Vivo Conditions

Nguyen PH, Sterpone F, Derreumaux P.

J Phys Chem B. 2022 Dec 15;126(49):10317-10326. doi: 10.1021/acs.jpcb.2c06375. Epub 2022 Dec 5.

Research Progress of Targeting Neuro-Immune Inflammation in the Treatment of Alzheimer's Disease

Chen H, Deng C, Meng Z, Meng S.

Front Biosci (Landmark Ed). 2022 Nov 25;27(11):312. doi: 10.31083/j.fbl2711312.

Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias

Yassine HN, Self W, Kerman BE, Santoni G, Navalpur Shanmugam N, Abdullah L, Golden LR, Fonteh AN, Harrington MG, Gräff J, Gibson GE, Kalaria R, Luchsinger JA, Feldman HH, Swerdlow RH, Johnson LA, Albensi BC, Zlokovic BV, Tanzi R, Cunnane S, Samieri C, Scarmeas N, Bowman GL.

Alzheimers Dement. 2023 Mar;19(3):1041-1066. doi: 10.1002/alz.12845. Epub 2022 Dec 8.

Natural Carotenoids as Neuroprotective Agents for Alzheimer's Disease: An Evidence-Based Comprehensive Review

Batool Z, Chen JH, Gao Y, Lu LW, Xu H, Liu B, Wang M, Chen F.

J Agric Food Chem. 2022 Dec 21;70(50):15631-15646. doi: 10.1021/acs.jafc.2c06206. Epub 2022 Dec 8.

Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease

Dhadda S, Kanekiyo M, Li D, Swanson CJ, Irizarry M, Berry S, Kramer LD, Berry DA.

Alzheimers Res Ther. 2022 Dec 9;14(1):182. doi: 10.1186/s13195-022-01129-x.

Beyond the classical amyloid hypothesis in Alzheimer's disease: Molecular insights into current concepts of pathogenesis, therapeutic targets, and study models

Theerasri A, Janpaijit S, Tencomnao T, Prasansuklab A.

WIREs Mech Dis. 2023 Mar;15(2):e1591. doi: 10.1002/wsbm.1591. Epub 2022 Dec 9.

Effect of a Vegan Diet on Alzheimer's Disease

Katonova A, Sheardova K, Amlerova J, Angelucci F, Hort J.

Int J Mol Sci. 2022 Nov 29;23(23):14924. doi: 10.3390/ijms232314924.

Synthetic, Cell-Derived, Brain-Derived, and Recombinant β-Amyloid: Modelling Alzheimer's Disease for Research and Drug Development

Varshavskaya KB, Mitkevich VA, Makarov AA, Barykin EP.

Int J Mol Sci. 2022 Nov 30;23(23):15036. doi: 10.3390/ijms232315036.

Disease-Modifying Activity of Huperzine A on Alzheimer's Disease: Evidence from Preclinical Studies on Rodent Models

Yan YP, Chen JY, Lu JH.

Int J Mol Sci. 2022 Dec 3;23(23):15238. doi: 10.3390/ijms232315238.

Gut Microbiota and Immunotherapy for Alzheimer's Disease

Dai CL, Liu F, Iqbal K, Gong CX.

Int J Mol Sci. 2022 Dec 3;23(23):15230. doi: 10.3390/ijms232315230.

Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets

Hamzé R, Delangre E, Tolu S, Moreau M, Janel N, Bailbé D, Movassat J.

Int J Mol Sci. 2022 Dec 4;23(23):15287. doi: 10.3390/ijms232315287.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias